LAUSR

This study aims to elucidate the prognostic and predictive biomarker of miR‐495 and Stat3 in peripheral blood in relation to lower extremity deep venous thrombosis (DVT). Patients with lower limb fractures were assigned into case and control groups. Rats were allocated into blank (normal rats), sham (normal rats), DVT, miR‐495 mimic, miR‐495 inhibitor, over‐Stat3, and si‐Stat3 groups. ELISA was used to detect levels of prothrombin time (PT), endothelin‐1 (ET‐1), Human Fibrinogen (FIB), D‐Dimer, blood coagulation factors V and VIII, tissue type plasminogen activator (t‐PA), platelet activating factor (PAF), protein C and Stat3. qRT‐PCR was employed for the evaluation of the expressions of miR‐495 and Stat3, while receiver operating characteristic (ROC) curve was constructed to assess the predictive value of miR‐495 and Stat3 as well as the treatment outcomes of patients with lower limb fractures. Logistic regression analyses were conducted in order to correlate indexes and lower extremity DVT. miR‐495 overexpression, t‐PA, PAF, and protein C were confirmed to be protective factors, while Stat3 overexpression, PT, ET‐1, FIB, D‐Dimer, blood coagulation factor V, and VIII were all ultimately considered to be risk factors of lower extremity DVT. Stat3 was confirmed to be the target gene of miR‐495. Compared with the blank group, the length and weight of the thrombus as well as the ratio between length and weight, mRNA and protein expression of Stat3 were reduced in the miR‐495 mimic and si‐Stat3 groups. Our findings suggest that through the suppression of Stat3 expression, miR‐495 prohibits lower extremity DVT in peripheral blood.